Clathrates of dehydroepiandrosterone and corresponding pharmaceutical compositions
CA 2355148 A1 · Owner: Euphar Group S.R.L. · Inventors: Corvi Mora, Paolo
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention refers to clathrates of dehydroepiandrosterone possibly , in the form of sulphate, in a matrix consisting of a cyclodextrin and optionally comprising a co-solubilization agent and to the corresponding , pharmaceutical compositions suitable for replacement therapy for the treatment of adrenocortical insufficiency, adrenopausal disorders hypogonadim and , xerophtalmia.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed December 16, 1999. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended December 16, 2019.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by December 16, 2021.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.